BIOTRONIK Conduction System Pacing With the Solia Lead

NACompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

January 9, 2024

Study Completion Date

October 8, 2024

Conditions
BradycardiaAtrioventricular BlockLeft Bundle-Branch BlockCardiomyopathies
Interventions
DEVICE

Solia S lead

The Solia S pacing lead will be implanted in the LBB area for patients who meet all inclusion/exclusion criteria and give written informed consent.

Trial Locations (14)

10016

NYU Langone Health, New York

10021

Weill Cornell Medicine, New York

18711

Geisinger, Wilkes-Barre

19107

Cardiology Consultants of Philadelphia, Philadelphia

20010

Washington Hospital Center, Washington D.C.

27157

Wake Forest University Health Sciences, Winston-Salem

29425

Medical University of South Carolina (MUSC), Charleston

33606

Tampa General Hospital, Tampa

34239

Sarasota Memorial Health Care System, Sarasota

38801

Cardiology Associates, Tupelo

60612

Rush University Medical Center, Chicago

60637

University of Chicago, Chicago

85006

Banner - University Medical Center Phoenix, Phoenix

93003

Cardiology Associates Medical Group, Ventura

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biotronik, Inc.

INDUSTRY